======= LTA4H ======= == Gene Information == * **Official Symbol**: LTA4H * **Official Name**: leukotriene A4 hydrolase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4048|4048]] * **UniProt**: [[https://www.uniprot.org/uniprot/P09960|P09960]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LTA4H&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LTA4H|Open PubMed]] * **OMIM**: [[https://omim.org/entry/151570|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Epoxide hydrolase that catalyzes the final step in the biosynthesis of the proinflammatory mediator leukotriene B4. Has also aminopeptidase activity. {ECO:0000269|PubMed:11917124, ECO:0000269|PubMed:12207002, ECO:0000269|PubMed:15078870, ECO:0000269|PubMed:18804029, ECO:0000269|PubMed:1897988, ECO:0000269|PubMed:1975494, ECO:0000269|PubMed:2244921}. |Leuk-A4-hydro C| |Peptidase M1| |leukotriene-A4 hydrolase activity| |epoxide hydrolase activity| |leukotriene biosynthetic process| |metalloaminopeptidase activity| |aminopeptidase activity| |long-chain fatty acid biosynthetic process| |peptide catabolic process| |leukotriene metabolic process| |icosanoid biosynthetic process| |tertiary granule lumen| |peptidase activity| |fatty acid derivative biosynthetic process| |icosanoid metabolic process| |long-chain fatty acid metabolic process| |fatty acid biosynthetic process| |ficolin-1-rich granule lumen| |fatty acid derivative metabolic process| |monocarboxylic acid biosynthetic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |fatty acid metabolic process| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |peptide metabolic process| |monocarboxylic acid metabolic process| |lipid biosynthetic process| |myeloid leukocyte activation| |small molecule biosynthetic process| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulated exocytosis| |leukocyte mediated immunity| |cellular amide metabolic process| |exocytosis| |zinc ion binding| |carboxylic acid metabolic process| |leukocyte activation| |cellular lipid metabolic process| |oxoacid metabolic process| |secretion by cell| |organic acid metabolic process| |export from cell| |organonitrogen compound catabolic process| |cell activation| |immune effector process| |secretion| |lipid metabolic process| |proteolysis| |RNA binding| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-1.92| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-1.73| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.7| |[[:results:exp224|CB-839 10μM R05 exp224]]|1.82| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|1.83| |[[:results:exp346|CoCl2 18μM R07 exp346]]|1.88| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.411| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12857 * **Expression level (log2 read counts)**: 7.17 {{:chemogenomics:nalm6 dist.png?nolink |}}